Geroprotectors slow down aging and promote healthy longevity in model animals. Although
hundreds of compounds have been shown to extend the life of laboratory model organisms …

Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we …

Background and objective IPF is a fatal and debilitating lung disorder increasing in
incidence worldwide. To date, two approved treatments only slow disease progression, have …

Introduction Fibroblastic foci represent the cardinal pathogenic lesion in idiopathic
pulmonary fibrosis (IPF) and comprise activated fibroblasts and myofibroblasts, the key …

A condition of scarring of lung tissue due to a wide range of causes (such as environmental
pollution, cigarette smoking (CS), lung diseases, some medications, etc.) has been reported …

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive
lung scarring due to unknown injurious stimuli ultimately leading to respiratory failure …

Objective. Idiopathic pulmonary fibrosis (IPF) is a common respiratory disease that can lead
to respiratory failure in severe condition. Despite notable advances in its treatment, some …

Idiopathic pulmonary fibrosis is a chronic and progressive interstitial lung disease with a
poor prognosis. Idiopathic pulmonary fibrosis is characterized by repeated alveolar …

Background: Recent studies have found a regulatory role of circular RNAs (circRNAs) in the
pathogenesis of idiopathic pulmonary brosis (IPF). However, the function and underlying …